SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVictrex Regulatory News (VCT)

Share Price Information for Victrex (VCT)

Share Price is delayed by 15 minutes
Get Live Data
620.00    9.00 (1.47%)
Bid:
621.00
Ask:
623.00
Spread: 2.00 (0.322%)
Market Cap: £540.17m
VCT Live PriceLast checked at - London Stock Exchange

Intraday Victrex Share Chart

Trading Statement

8 Oct 2015 07:00

RNS Number : 5861B
Victrex PLC
08 October 2015
 



 

 

 

 

 

 

8 October 2015

 

Victrex plc - Full year pre-close trading update

 

"A good finish to 2015"

 

Victrex plc, an innovative world leader in high performance polymer solutions, today announces its full year pre-close trading update for the financial year ended 30 September 2015, ahead of its preliminary results on 8 December 2015.

 

Victrex delivered a good finish to 2015, with overall performance in line with our expectations, including a robust fourth quarter (Q4). For the year as a whole, the value of our balanced portfolio helped to drive growth and fully overcome headwinds including weaker sales in Oil & Gas, the effects of US Spine market consolidation on our Invibio medical business and the significant impact from foreign currency this year.

 

On a reported basis, full year Group revenue of £263.5m was 4% ahead of the prior year (FY 2014: £252.6m), with Q4 Group revenue of £68.7m being flat on the prior year period. Foreign currency, at a profit level, was a headwind of approximately £8m for the full year, which we will fully overcome.

 

At a volume level, full year Group sales volume of 4,217 tonnes was 19% ahead of the prior year (FY 2014: 3,551 tonnes). Q4 Group sales volume of 1,119 tonnes was 6% ahead of the prior year period (Q4 2014: 1,056 tonnes). Sales volumes reflect our overall momentum in VPS remaining positive during the fourth quarter, with growth across Aerospace, Automotive, General Industrial and strong Consumer Electronics volumes offsetting Oil & Gas, as previously communicated.

 

Invibio performance was in line with our previous guidance, with full year revenue of £50.5m being 5% down compared to the prior year (FY 2014: £53.4m). This reflects the effects of consolidation in the US Spine market.

 

Outlook

Our overall growth momentum remains positive as we start our new financial year. Whilst we are mindful of the continuing weakness in Oil & Gas and the need to improve Invibio performance in 2016, our balanced portfolio keeps us well placed to continue driving growth and creating value, in line with our long term strategy.

 

Enquiries:

 

Victrex plc:

Andrew Hanson, Head of Investor Relations & Communications +44 (0) 1253 898121

Louisa Burdett, Group Finance Director +44 (0) 1253 897700

David Hummel, Chief Executive +44 (0) 1253 897700

 

Pendomer Communications:

Charles Armitstead +44 (0) 203 603 5220

 

About Victrex:

Victrex is an innovative world leader in high performance polymer solutions focused on the Aerospace, Automotive, Electronics, Energy and Medical markets. Every day, millions of people rely on products or applications which contain our polymers, from smartphones, aeroplanes and cars to oil & gas operations and medical devices. With over 35 years' experience, we are delivering leading edge solutions to shape future performance for our customers and our markets, and to drive value for our shareholders. Find out more at www.victrexplc.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTUGGQWUUPAGAM
Date   Source Headline
16th Dec 20154:37 pmRNSDirector/PDMR Shareholding
15th Dec 201512:03 pmRNSDirector/PDMR Shareholding
9th Dec 20152:34 pmRNSDirector/PDMR Shareholding
8th Dec 20154:43 pmRNSHolding(s) in Company
8th Dec 20157:00 amRNSFinal Results
4th Dec 20154:07 pmRNSHolding(s) in Company
1st Dec 20154:49 pmRNSHolding(s) in Company
1st Dec 20152:54 pmRNSBlocklisting Interim Review
30th Nov 20153:39 pmRNSTotal Voting Rights
20th Nov 20154:04 pmRNSHolding(s) in Company
17th Nov 20154:08 pmRNSDirector/PDMR Shareholding
30th Oct 201510:32 amRNSTotal Voting Rights
19th Oct 20153:13 pmRNSDirector/PDMR Shareholding
8th Oct 20157:00 amRNSTrading Statement
30th Sep 20151:56 pmRNSTotal Voting Rights
29th Sep 20154:19 pmRNSDirectorate Change
28th Sep 20154:28 pmRNSDirector/PDMR Shareholding
24th Sep 201511:50 amRNSDirector/PDMR Shareholding
21st Sep 201511:42 amRNSHolding(s) in Company
17th Sep 201511:23 amRNSDirector/PDMR Shareholding
28th Aug 201512:06 pmRNSTotal Voting Rights
26th Aug 20154:24 pmRNSHolding(s) in Company
18th Aug 20152:12 pmRNSDirector/PDMR Shareholding
31st Jul 20154:09 pmRNSTotal Voting Rights
31st Jul 20152:24 pmRNSHolding(s) in Company
31st Jul 201512:08 pmRNSDirectorate Change
21st Jul 20157:00 amRNSInterim Management Statement
20th Jul 20159:58 amRNSDirector/PDMR Shareholding
30th Jun 20153:38 pmRNSTotal Voting Rights
26th Jun 201511:07 amRNSDirector Declaration
17th Jun 20154:06 pmRNSDirector/PDMR Shareholding
1st Jun 20153:52 pmRNSBlocklisting Interim Review
29th May 201510:00 amRNSTotal Voting Rights
26th May 20154:39 pmRNSDirector/PDMR Shareholding
19th May 20153:58 pmRNSDirector/PDMR Shareholding
19th May 20159:52 amRNSVictrex first half pretax profit jumps 10%
19th May 20157:00 amRNSHalf Yearly Report
11th May 20154:31 pmRNSHolding(s) in Company
6th May 20154:34 pmRNSHolding(s) in Company
30th Apr 20152:30 pmRNSTotal Voting Rights
28th Apr 20154:34 pmRNSHolding(s) in Company
21st Apr 20157:00 amRNSCapital Markets Day
20th Apr 20153:23 pmRNSDirector/PDMR Shareholding
9th Apr 20157:00 amRNSTrading Statement
31st Mar 20153:25 pmRNSTotal Voting Rights
26th Mar 20153:20 pmRNSDirectorate Change
23rd Mar 20157:00 amRNSDirectorate Change
19th Mar 20154:32 pmRNSHolding(s) in Company
17th Mar 20152:28 pmRNSDirector/PDMR Shareholding
5th Mar 20157:00 amRNSAdditional Listing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.